HCW Biologics Inc. Profile Avatar - Palmy Investing

HCW Biologics Inc.

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injecta…

Biotechnology
US, Miramar [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

HCW Biologics Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

HCW Biologics Inc. can't present revenue by segment

End of HCWB's Analysis
CIK: 1828673 CUSIP: 40423R105 ISIN: US40423R1059 LEI: - UEI: -
Secondary Listings
HCWB has no secondary listings inside our databases.